topical everolimus
Showing 1 - 25 of 4,569
Stomatitis, Oral Mucositis, Tumor of the Breast Trial in US (Miracle Mouthwash Plus Hydrocortisone, Prednisolone)
Completed
- Stomatitis
- +3 more
- Miracle Mouthwash Plus Hydrocortisone
- Prednisolone
-
US, Texas12 sites incl Yakima, WA, Boulder, CO, and Austin, TX
Nov 29, 2022
Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)
Completed
- Glioblastoma Multiforme
- Glioma of Brain
-
Chandler, Arizona
- +2 more
Jan 11, 2023
Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and
Not yet recruiting
- Breast Cancer
- Advanced Breast Cancer
- Everolimus 10 mg
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 14, 2023
Aging Trial in Madison (Sirolimus, Everolimus)
Not yet recruiting
- Aging
-
Madison, WisconsinUniversity of Wisconsin
Jul 17, 2023
Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)
Not yet recruiting
- Neuroendocrine Tumors
- +2 more
-
Bourdeaux, France
- +24 more
Jun 23, 2023
Metastatic Breast Cancer Trial in France (Biopsy)
Completed
- Metastatic Breast Cancer
- Biopsy
-
Angers, France
- +11 more
Sep 19, 2022
Androgenetic Alopecia Trial in Jakarta Pusat (Platelet-Rich Plasma and Topical 5% Minoxidil, Topical 5% Minoxidil)
Active, not recruiting
- Androgenetic Alopecia
- Platelet-Rich Plasma and Topical 5% Minoxidil
- Topical 5% Minoxidil
-
Jakarta Pusat, Greater Jakarta Area, IndonesiaDr. Cipto Mangunkusumo National General Hospital
Sep 12, 2023
Alopecia Areata Trial in Assiut (Betamethasone Valerate 0.1% Cream, Pentoxifylline, Metformin)
Not yet recruiting
- Alopecia Areata
- Betamethasone Valerate 0.1% Cream
- +2 more
-
Assiut, EgyptAssiut university
Oct 15, 2023
Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in
Recruiting
- Recurrent Endometrial Carcinoma
- +12 more
- Everolimus
- +2 more
-
Houston, Texas
- +1 more
Sep 22, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory
Recruiting
- Advanced Malignant Neoplasm
- +3 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Androgenetic Alopecia Trial in Jakarta (Finasteride, Minoxidil)
Recruiting
- Androgenetic Alopecia
-
Jakarta, Other (Non U.s.), IndonesiaUniversity Indonesia
Aug 4, 2023
Aging, Insulin Resistance Trial in Madison (Everolimus 0.5 MG once per day, Everolimus 5 MG once per week, Placebo once per day)
Recruiting
- Aging
- Insulin Resistance
- Everolimus 0.5 MG once per day
- +3 more
-
Madison, WisconsinUniversity of Wisconsin-Madison
Apr 19, 2023
Idiopathic Subglottic Tracheal Stenosis Trial in Baltimore (Everolimus Oral Tablet)
Recruiting
- Idiopathic Subglottic Tracheal Stenosis
- Everolimus Oral Tablet
-
Baltimore, MarylandJohns Hopkins Outpatient Center
Jul 28, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- sorafenib tosylate
- +4 more
-
Aurora, Colorado
- +1 more
Sep 8, 2022
Malignant Tumor Trial in United States (Dexamethasone, Placebo, Questionnaire)
Oral Ulceration Due to Behçet's Disease Trial (Rebamipide mouthwash, Betamethasone mouthwash)
Not yet recruiting
- Oral Ulceration Due to Behçet's Disease
- Rebamipide mouthwash
- Betamethasone mouthwash
- (no location specified)
Oct 13, 2023
Advanced Breast Cancer Trial in China (Everolimus, Exemestane, Everolimus Placebo)
Completed
- Advanced Breast Cancer
- Everolimus
- +2 more
-
Guangzhou, Guangdong, China
- +14 more
Jun 17, 2022
Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)
Not yet recruiting
- Metastatic Midgut Neuroendocrine Tumor
- Unresectable Midgut Neuroendocrine Tumor
- Biospecimen Collection
- +5 more
- (no location specified)
Mar 16, 2023
Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston
Recruiting
- Advanced Carcinoid Tumor
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
-
Birmingham, Alabama
- +11 more
May 6, 2022
Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)
Completed
- Acute Lymphoblastic Leukemia
- Everolimus
- +5 more
-
San Francisco, California
- +7 more
Aug 5, 2022